Loading clinical trials...
Loading clinical trials...
This study aimed to develop and clinically evaluate a novel hollow cusp fracture reducer for enhancing the precision and efficiency of closed reduction and internal fixation in patients with femoral s...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hanzhong Central Hospital
NCT07381725 · Single Lateral Plate, Double Plating, and more
NCT06382584 · Direct Oral Anticoagulants (DOACs), Femoral Fractures, and more
NCT06652334 · Femoral Fractures
NCT01254942 · Hip Fractures, Femoral Fractures
NCT05737459 · Cognitive Impairment, Femoral Fractures
Hanzhong Central Hospital
Hanzhong, Shaanxi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions